EHAB.NYSEEnhabit, INC

10-K/A: Enhabit Inc. Files Amended 10-K Report, Disclosing Executive Compensation and Governance Details

Sentiment:

Annual Report Amendment


Enhabit, Inc. has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Delay expectedThe company's 2024 proxy statement will not be filed within the requisite time period to allow incorporation by reference, necessitating the filing of this amendment.
Worse than expectedThe company's Adjusted EBITDA of $97.6 million was below the threshold required for the Senior Management Bonus Plan, resulting in a payout of only 52.5% of target.

Summary

  • Enhabit, Inc. filed an amendment to its annual report on Form 10-K to include information previously omitted regarding directors, executive officers, and corporate governance.
  • The amendment includes details on executive compensation, director compensation, and the company's corporate governance practices.
  • The company's 2023 financial performance included consolidated net revenue of $1,046.3 million and adjusted EBITDA of $97.6 million.
  • The Senior Management Bonus Plan (SMBP) paid out at 52.5% of target based on the achievement of quality of care performance metrics.
  • The company hired 597 net new full-time nurses and eliminated all agency nursing contract labor in 2023.
  • Enhabit opened eight de novo locations in 2023, with two additional locations pending regulatory approval.
  • The company's 30-day hospital readmission rate was 20.5% better than the national average, and hospice visits in the last days of life were 53.2% better than the national average.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While the company has achieved significant operational milestones and quality of care metrics, it missed its financial targets, leading to a lower bonus payout. The document is factual and detailed, but the missed financial target tempers the overall sentiment.

Positives

  • Enhabit successfully negotiated 41 new Medicare Advantage agreements, including two national agreements.
  • The company eliminated all agency nursing contract labor in both home health and hospice.
  • Enhabit met or exceeded all key quality of care performance metrics.
  • The company has a strong focus on aligning executive compensation with company performance and shareholder value.
  • The company has implemented a clawback policy for incentive compensation.

Negatives

  • The Senior Management Bonus Plan (SMBP) did not pay out at 100% of target due to not meeting the Adjusted EBITDA target.
  • The company experienced challenges in the industry, including shifts in home health payor mix and increasing labor costs.

Risks

  • The company faces risks related to shifts in home health payor mix and increasing labor costs.
  • There are risks associated with the company's recent separation from Encompass Health Corporation.
  • The company is subject to regulatory compliance and cyber risk management activities.

Future Outlook

The document does not contain specific forward-looking statements, but it does outline changes to the 2024 SMBP to better align pay with financial goals.

Management Comments

  • Ms. Jacobsmeyer, as our President and Chief Executive Officer, directs the strategic, financial and operational management of the Company and, in this capacity, provides unique insights into its detailed operations.
  • The Compensation Committee concentrated on performance goals and metrics in the senior management bonus plan and the long-term equity incentive plan and peer alignment in the overall compensation program.

Industry Context

The document highlights challenges in the home health industry, such as shifts in payor mix and increasing labor costs, which are common trends in the healthcare sector. The company's focus on quality of care and strategic partnerships with Medicare Advantage plans reflects a broader industry trend towards value-based care.

Comparison to Industry Standards

  • The company's compensation peer group includes companies like Addus HomeCare Corporation, Amedisys, Inc., and LHC Group, Inc., which are all major players in the home health and healthcare services industry.
  • Enhabit's 30-day hospital readmission rate being 20.5% better than the national average indicates a strong performance compared to industry benchmarks.
  • The company's hospice visits in the last days of life being 53.2% better than the national average also demonstrates a high level of service quality compared to industry standards.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Committee RestructuringThe Board combined the Audit Committee and Finance Committee and changed the name of the Compliance/Quality of Care Committee to the Care, Compliance & Cybersecurity Committee in February 2024.February 2024This change is intended to streamline oversight and improve efficiency.

Legal Proceedings

  • The company is involved in a lawsuit, Enhabit, Inc. et al. v. Nautic Partners IX, L.P., et al., where it has asserted claims for breach of fiduciary duty, aiding and abetting, and usurpation of corporate opportunity.

Stakeholder Impact

  • Shareholders are impacted by the company's financial performance and executive compensation decisions.
  • Employees are impacted by the company's compensation and benefits programs, as well as its focus on talent acquisition and retention.
  • Patients are impacted by the company's focus on quality of care and patient experience.
  • The company's performance impacts its relationships with Medicare Advantage plans and other payors.

Next Steps

  • The company will continue to focus on improving financial performance and quality of care.
  • The Compensation Committee will continue to review and adjust compensation programs to align with company objectives.
  • The company will continue to execute its strategic plan over the next three years.

Key Dates

DateDescription
March 7, 2022Encompass Health Home Health Holdings, Inc. changed its name to Enhabit, Inc.
July 1, 2022Encompass completed the separation of Enhabit through the distribution of shares to Encompass stockholders.
December 31, 2023End of the fiscal year for which the report is filed.
March 15, 2024Initial filing of the Annual Report on Form 10-K.
April 17, 2024Date of outstanding shares of common stock.
April 26, 2024Date of filing of the Amendment No. 1 to Annual Report on Form 10-K.

Keywords

executive compensation, corporate governance, home health, hospice, adjusted EBITDA, financial performance, quality of care, healthcare services, incentive compensation, board of directors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.